(Q43988430)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12003675%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Molecular, immunological and clinical properties of mutated hepatitis B viruses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12003675%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

1 reference

C Kreutz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12003675%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12003675%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cellular and Molecular Medicine

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12003675%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12003675%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12003675%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

113-143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12003675%20AND%20SRC:MED&resulttype=core&format=json

Vaccine-induced escape mutant of hepatitis B virus

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Selection for a pre-C stop codon mutation in a hepatitis B virus variant with a pre-C initiation codon mutation during interferon treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end-stage liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Analysis of the hepatitis B virus genome and immune response in HBsAg, anti-HBs positive chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Intra-familial evidence of horizontal transmission of hepatitis B virus surface antigen mutant G145R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Current aspects of hepatitis B surface antigen mutants in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Variant of hepatitis B virus isolated in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Molecular epidemiology of hepatitis B virus vaccine variants in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the 'a' epitope of the surface antigen are sensitive to ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Sequence analysis of pre-S/S gene of hepatitis B virus strains of genotypes A, D, and F isolated in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B virus mutations in the pre-S genome before and after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

The hepatitis B virus seroconversion to anti-HBe is frequently associated with HBV genotype changes and selection of preS2-defective particles in chronically infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Conservation of precore and core sequences of hepatitis B virus in chronic viral carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Prevalence of precore‐defective mutant of hepatitis B virus in HBV carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

A precore-defective mutant of hepatitis B virus associated with e antigen-negative chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

The Mechanism of Natural Occurrence of Two Closely Linked HBV Precore Predominant Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B virus precore mutants in serum and liver of Southern African Blacks with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Clinical and molecular virological differences between fulminant hepatic failures following acute and chronic infection with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B virus variants in patients with acute hepatitis in whom various clinical forms develop

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Genetic heterogeneity in the precore region of hepatitis B virus in hepatitis B e antigen‐negative chronic hepatitis B Patients: Spontaneous seroconversion and interferon‐induced seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Frequent integration of precore/core mutants of hepatitis B virus in human hepatocellular carcinoma tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Comparison of pre-core/core hepatitis B virus region in liver tissue and serum from patients with chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Sequence analysis of the hepatitis B virus pre-C region in hepatocellular carcinoma [HCC] and nontumoral liver tissues from HCC patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

High circulation of hepatitis B virus (HBV) precore mutants in Tunisia, North Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Translational inactivation of RNA function: discrimination against a subset of genomic transcripts during HBV nucleocapsid assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Viral genetic variation: hepatitis B virus as a clinical example

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Three cases of severe subfulminant hepatitis in heart-transplanted patients after nosocomial transmission of a mutant hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Variations of hepatitis B virus precore/core gene sequence in acute and fulminant hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Human and murine B-cells recognize the HBeAg/beta (or HBe2) epitope as a linear determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

A frequent, naturally occurring mutation (P130T) of human hepatitis B virus core antigen is compensatory for immature secretion phenotype of another frequent variant (I97L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Characterization of hepatitis B virus core mutants that inhibit viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

A hepatitis B virus mutant with a new hepatocyte nuclear factor 1 binding site emerging in transplant-transmitted fulminant hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B virus core antigen (HBc Ag) accumulation in an HBV nonproducer clone of HepG2-transfected cells is associated with cytopathic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Treatment with interferon of chronic hepatitis B associated with antibody to hepatitis B e antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

In vitro tumorigenicity of hepatitis B virus DNA and HBx protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

The hepatitis B virus-encoded transcriptional trans-activator hbx appears to be a novel protein serine/threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B virus pX targets TFIIB in transcription coactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Detection of mutations in hepatitis B virus enhancer 2/core promoter and X protein regions in patients with fatal hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Complete nucleotide sequences and the characteristics of two hepatitis B virus mutants causing serologically negative acute or chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

"Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Deletion mutants of the hepatitis B virus X gene in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

The nucleotide sequence and reading frames of a mutant hepatitis B virus subtype adr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Detection of a hepatitis B virus variant with a truncated X gene and enhancer II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Naturally occurring hepatitis B virus mutants with deletions in the core promoter region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

X region deletion mutants associated with surface antigen-positive hepatitis B virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Reduced antigen production by hepatitis B virus harbouring nucleotide deletions in the overlapping X gene and precore-core promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

A liver-specific enhancer in the core promoter region of human hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Probable implication of mutations of the X open reading frame in the onset of fulminant hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: comparison with mutations in precore and core regions in relation to clinical status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) --> T, A(1762) --> T and G(1764) --> A mutations in the core promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Mutations in the core promoter region of hepatitis B virus in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L(-)SddC (3TC) resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Are booster immunisations needed for lifelong hepatitis B immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Mutations in S region of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Detection of hepatitis B virus precore TAG mutant by an amplification-created restriction site method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy using the LightCycler

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Functional analysis of HBV genomes from patients with fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B virus genomes from long-term immunosuppressed virus carriers are modified by specific mutations in several regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Hepatitis B genotypes and the response to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Emergence and selection of HBV variants in an anti-HBe positive patient persistently infected with quasi-species

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

21 January 2018

The hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2002.TB00317.X

Selection of hepatitis B surface "escape" mutants during passive immune prophylaxis following liver transplantation: potential impact of genetic changes on polymerase protein function

21 January 2018

1 reference

12 December 2020

Immunoassay detection of hepatitis B surface antigen mutants

1 reference

12 December 2020

Subtype-independent immature secretion and subtype-dependent replication deficiency of a highly frequent, naturally occurring mutation of human hepatitis B virus core antigen.

1 reference

12 December 2020

Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin

1 reference

12 December 2020

Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy

1 reference

12 December 2020

Analysis of hepatitis B virus quasispecies changes during emergence and reversion of lamivudine resistance in liver transplantation.

1 reference

12 December 2020

Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity

1 reference

12 December 2020

Horizontal transmission of a hepatitis B virus surface antigen mutant.

1 reference

12 December 2020

De novo acute hepatitis B infection in a previously vaccinated liver transplant recipient due to a strain of HBV with a Met 133 Thr mutation in the "a" determinant

1 reference

12 December 2020

A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group

1 reference

12 December 2020

Genetic mutations of precore region of hepatitis B virus in hepatitis B e antigen-negative patients with fulminant hepatitis B and translation of precore variants in vitro

1 reference

12 December 2020

Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy

1 reference

12 December 2020

Fine specificity of the human T cell response to hepatitis B virus core antigen

1 reference

12 December 2020

Naturally occurring point mutation in the C terminus of the polymerase gene prevents duck hepatitis B virus RNA packaging

1 reference

12 December 2020

Replication of a mutant hepatitis B virus with a fused X-C reading frame in hepatoma cells

1 reference

12 December 2020

Molecular basis of hepatitis B virus serotype variations within the four major subtypes

1 reference

12 December 2020

Replication of DHBV genomes with mutations at the sites of initiation of minus- and plus-strand DNA synthesis

1 reference

12 December 2020

Mapping of 5' ends of virion-derived HBV DNA

1 reference

12 December 2020

Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus

1 reference

12 December 2020

The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly

1 reference

12 December 2020

Effects of insertional and point mutations on the functions of the duck hepatitis B virus polymerase

1 reference

12 December 2020

Molecular heterogeneity of e antigen polypeptides in sera from carriers of hepatitis B virus

1 reference

12 December 2020

Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection

1 reference

12 December 2020

Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion

1 reference

12 December 2020

Hepatitis B virus X protein is not central to the viral life cycle in vitro

1 reference

12 December 2020

Precore mutant hepatitis B virus infection and liver disease

1 reference

12 December 2020

Detection of pre-C and core region mutants of hepatitis B virus in chronic hepatitis B virus carriers

1 reference

12 December 2020

Topoisomerase I-mediated integration of hepadnavirus DNA in vitro

1 reference

12 December 2020

Prevalence and type of pre-C HBV mutants in anti-HBe positive carriers with chronic liver disease in a highly endemic area

1 reference

12 December 2020

The quaternary structure, antigenicity, and aggregational behavior of the secretory core protein of human hepatitis B virus are determined by its signal sequence.

1 reference

12 December 2020

Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen

1 reference

12 December 2020

Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication

1 reference

12 December 2020

Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis

1 reference

12 December 2020

A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis

1 reference

12 December 2020

Defects in the precore region of hepatitis B virus DNA in a plasma pool from carriers seropositive for antibody against e antigen and with infectivity in chimpanzees

1 reference

12 December 2020

Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity

1 reference

12 December 2020

Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors

1 reference

12 December 2020

The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function

1 reference

12 December 2020

Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein

1 reference

12 December 2020

A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA.

1 reference

12 December 2020

Rapid detection and further characterization of infection with hepatitis B virus variants containing a stop codon in the distal pre-C region

1 reference

12 December 2020

Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen

1 reference

12 December 2020

Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA

1 reference

12 December 2020

The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element.

1 reference

12 December 2020

The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-I tax.

1 reference

12 December 2020

Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region

1 reference

12 December 2020

Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg

1 reference

12 December 2020

Comparative immunogenicity of hepatitis B virus core and E antigens

1 reference

12 December 2020

Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus

1 reference

12 December 2020

Features of two hepatitis B virus (HBV) DNA integrations suggest mechanisms of HBV integration

1 reference

12 December 2020

Identification of four conserved motifs among the RNA-dependent polymerase encoding elements

1 reference

12 December 2020

The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma

1 reference

12 December 2020

The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription

1 reference

12 December 2020

Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer.

1 reference

12 December 2020

Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes

1 reference

12 December 2020

Cloning and analysis of integrated hepatitis virus sequences from a human hepatoma cell line

1 reference

12 December 2020

Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides

1 reference

12 December 2020

Distribution of HBsAg subtypes in the world

1 reference

12 December 2020

Hepatitis B virus infection: precore mutants and its relation to viral genotypes and core mutations

1 reference

12 December 2020

Precore and X region mutants in hepatitis B virus infections among renal dialysis patients

1 reference

12 December 2020

Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase

1 reference

12 December 2020

Predictive value of precore hepatitis B virus mutations in spontaneous and interferon-induced hepatitis B e antigen clearance

1 reference

12 December 2020

Nucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase expressed in insect cells

1 reference

12 December 2020

Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection

1 reference

12 December 2020

Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus

1 reference

12 December 2020

Hepatitis B virus precore/core variation and interferon therapy

1 reference

12 December 2020

Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e–minus hepatitis B virus mutants

1 reference

12 December 2020

Modulation of intracellular signal transduction pathways by the hepatitis B virus transactivator pX.

1 reference

12 December 2020

Study on the comparative immunogenicity of a recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein with non pre-S containing vaccines

1 reference

12 December 2020

A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients

1 reference

12 December 2020

Allelic subtypic determinants of hepatitis B surface antigen (i and t) that are distinct from d/y or w/r

1 reference

12 December 2020

Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein

1 reference

12 December 2020

Translation of the hepatitis B virus P gene by ribosomal scanning as an alternative to internal initiation

1 reference

12 December 2020

Novel mechanism for reverse transcription in hepatitis B viruses

1 reference

12 December 2020

Variants of hepatitis B, C and D viruses: molecular biology and clinical significance

1 reference

12 December 2020

[Progress in hepatitis diagnosis]

1 reference

12 December 2020

Analysis of the precore DNA sequence and detection of precore antigen in liver specimens from patients with anti-hepatitis B e-positive chronic hepatitis

1 reference

12 December 2020

Fibronectin of human liver sinusoids binds hepatitis B virus: identification by an anti-idiotypic antibody bearing the internal image of the pre-S2 domain

1 reference

12 December 2020

Nucleotide sequence analysis of precore and proximal core regions in patients with chronic hepatitis B treated with interferon

1 reference

12 December 2020

Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation

1 reference

12 December 2020

Hepatitis B virus transactivator protein X interacts with the TATA-binding protein.

1 reference

12 December 2020

Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.

1 reference

12 December 2020

Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen

1 reference

12 December 2020

Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes

1 reference

12 December 2020

Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis

1 reference

12 December 2020

Pathogenesis of posttransfusion viral hepatitis in children with β-thalassemia

1 reference

12 December 2020

Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen

1 reference

12 December 2020

Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer.

1 reference

12 December 2020

Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein.

1 reference

12 December 2020

Hepatitis B virus preC mutants in human hepatocellular carcinoma tissues

1 reference

12 December 2020

Detection of the hepatitis B virus major pre-core mutation by the amplification refractory mutation system technique

1 reference

12 December 2020

Trans-complementation among naturally occurring deletion mutants of hepatitis B virus and integrated viral DNA for the production of viral particles with mutant genomes in hepatoma cell lines

1 reference

12 December 2020

Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States

1 reference

12 December 2020

Hepatitis B virus: significance of naturally occurring mutants

1 reference

12 December 2020

Precore mutations and core clustering mutations in chronic hepatitis B virus infection

1 reference

12 December 2020

Structure of hepatitis B virus core and e-antigen. A single precore amino acid prevents nucleocapsid assembly.

1 reference

12 December 2020

Relevance of cysteine residues for biosynthesis and antigenicity of human hepatitis B virus e protein

1 reference

12 December 2020

Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis

1 reference

12 December 2020

Detection of hepatitis B virus precore stop codon mutants by selective amplification method: frequent detection of precore mutants in hepatitis B e antigen positive healthy carriers

1 reference

12 December 2020

A family cluster of an immune escape variant of hepatitis B virus infecting a mother and her two fully immunized children

1 reference

12 December 2020

Frequency and clinical profile of precore and surface hepatitis B mutants in Asian-Indian patients with chronic liver disease

1 reference

12 December 2020

Novel pre-C/C gene mutants of hepatitis B virus in chronic active hepatitis: naturally occurring escape mutants

1 reference

12 December 2020

Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication

1 reference

12 December 2020

Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.

1 reference

12 December 2020

A new pre-S containing recombinant hepatitis B vaccine and its effect on non-responders: a preliminary observation

1 reference

12 December 2020

Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis

1 reference

12 December 2020

Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo

1 reference

12 December 2020

Precore mutant of hepatitis B virus prevails in acute and chronic infections in an area in which hepatitis B is endemic

1 reference

12 December 2020

Variability in hepatitis B virus DNA: phylogenetic, epidemiological and clinical implications

1 reference

12 December 2020

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

1 reference

12 December 2020

Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication

1 reference

12 December 2020

Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.

1 reference

12 December 2020

Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection

1 reference

12 December 2020

Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen

1 reference

12 December 2020

The small envelope protein is required for secretion of a naturally occurring hepatitis B virus mutant with pre-S1 deleted.

1 reference

12 December 2020

Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales

1 reference

12 December 2020

A short linear sequence in the pre-S domain of the large hepatitis B virus envelope protein required for virion formation

1 reference

12 December 2020

Hepatitis B virus X protein interferes with cellular DNA repair.

1 reference

12 December 2020

Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: no association between genome conversion and seroconversion

1 reference

12 December 2020

Functional characterization of naturally occurring variants of human hepatitis B virus containing the core internal deletion mutation

1 reference

12 December 2020

Mutations in the 'a' determinant of hepatitis B surface antigen among Chinese infants receiving active postexposure hepatitis B immunization

1 reference

12 December 2020

Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity

1 reference

12 December 2020

Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors

1 reference

12 December 2020

The M539V polymerase variant of human hepatitis B virus demonstrates resistance to 2'-deoxy-3'-thiacytidine and a reduced ability to synthesize viral DNA

1 reference

12 December 2020

Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants

1 reference

12 December 2020

Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation.

1 reference

12 December 2020

10.1111/J.1582-4934.2002.TB00317.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12003675%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12003675%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

PubMed publication ID

12003675

1 reference